Effects of Exercise Frequency on Muscle Size and Strength in Healthy, Untrained Young Adults (FREQ)
11. August 2026 aktualisiert von: Cameron Mitchell
Resistance training (RT) is important for building and maintaining healthy muscles.
An exercise frequency called "exercise snacks" involves short bursts of exercise throughout the day (~5-15 minutes), but no studies have examined a gym-based RT exercise snack program.
The invetigators will randomize 40 participants into one of two groups for 10 weeks: the control group will complete two full-body workouts per week (standard-frequency) and the experimental group will complete 10 mini-workouts per week (high-frequency).
Muscle hypertrophy (size) and strength will be measured before and after the exercise program to determine if the participants had the same or different results.
Studienübersicht
Status
Rekrutierung
Studientyp
Interventionell
Einschreibung (Geschätzt)
40
Phase
- Unzutreffend
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienkontakt
- Name: Cameron Mitchell, PhD
- Telefonnummer: 604-827-2072
- E-Mail: cameron.mitchell@ubc.ca
Studienorte
-
-
British Columbia
-
Vancouver, British Columbia, Kanada, V6T 1Z1
- Rekrutierung
- University of British Columbia | Gateway Health Building
-
Kontakt:
- Cameron Mitchell, PhD
- Telefonnummer: 604-827-2072
- E-Mail: cameron.mitchell@ubc.ca
-
Kontakt:
- E-Mail: hdennis@student.ubc.ca
-
Unterermittler:
- Haley Dennis, MSc
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
Akzeptiert gesunde Freiwillige
Ja
Beschreibung
Inclusion Criteria:
- Can fluently read and write in English
- Lives, works, and/or studies at or near the Gateway Health Building (where all study visits will occur)
- Willing and able to commit to 2 or 10 in-person training sessions per week for 10 continuous weeks, as well as one week of testing before the training period and one week of testing after the training period
- Has continuous access to smartphone or other device that they can use to access the Technogym app
- Answers "No" to all questions on the Canadian Society for Exercise Physiology - Get Active Questonnaire (CSEP-GAQ) or has their doctor's approval to participate
Exclusion Criteria:
- Any major uncontrolled cardiovascular, muscular, metabolic, and/or neurological disorders
- Lung disease, kidney disease, or liver disease
- Current diagnosis of type 1 diabetes, type 2 diabetes, or cancer
- Medical conditions that limit their ability to undertake strenuous physical activity
- Regular use of any medications that may affect muscle physiology or body composition (i.e. benzodiazepines, hormone replacement therapy, ADHD medication, Metformin, Ozempic)
- Participated in consistent resistance exercise training more than twice per month in the previous 12 months
- Participated in consistent moderate or vigorous aerobic training more than twice per week in the previous 12 months, or planning to start consistent training in the next few months
- Significant gain or loss of body mass in the past 6 months (greater than 2 kg)
- Current smoker (including but not limited to cigarettes, e-cigarettes, or vaping)
- Body Mass Index of less than 18 kg/m2 or over 30 kg/m2
- Pregnancy or breastfeeding
- Currently taking blood thinners
- Allergic to Tegaderm medical tape (used with the activity trackers)
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Grundlegende Wissenschaft
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Aktiver Komparator: Standard-frequency resistance training
|
Full-body resistance training consisting of 10 sets per week for all major muscle groups with progressive overload in a gym-based setting.
Training at an exercise frequency of two sessions per week (around 45-60 minutes per session).
|
|
Experimental: High-frequency resistance training
|
Full-body resistance training consisting of 10 sets per week for all major muscle groups with progressive overload in a gym-based setting.
Training at an exercise frequency of 10 brief sessions per week (around 8-12 minutes per session).
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
|---|---|
|
Change in Total Body Skeletal Muscle Mass Measured using the D3-Creatine Dilution Method
Zeitfenster: From enrolment (Week 1) to the end of the exercise training phase (Week 12)
|
From enrolment (Week 1) to the end of the exercise training phase (Week 12)
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in Total Body Muscle Size Measured as Cross-sectional Area using Muscle Ultrasound Imaging
Zeitfenster: From enrolment (Week 1) to the end of the exercise training phase (Week 12)
|
Muscle ultrasound imaging will be conducted on one randomly selected side of the body (left or right) for each participant.
Scans will be analyzed to determine the cross-sectional area of the following seven muscles: rectus femoris, vastus lateralis, biceps brachii, pectoralis major, latissimus dorsi, triceps brachii, and hamstring group (semitendinosus, semimembranosus, and long head of biceps femoris).
|
From enrolment (Week 1) to the end of the exercise training phase (Week 12)
|
|
Change in Muscle Strength Measured as the One-Repetition Maximum of Back Squat and Bench Press
Zeitfenster: From enrolment (Week 1) to the end of the exercise training phase (Week 12)
|
One-repetition maximums will be measured using a Quantum Synchro Smith Machine.
|
From enrolment (Week 1) to the end of the exercise training phase (Week 12)
|
|
Change in Skeletal Muscle Power Measured at Various Relative Loads for Back Squat and Bench Press
Zeitfenster: From enrolment (Week 1) to the end of the exercise training phase (Week 12)
|
At enrolment (Week 1), power will be measured using a Quantum Synchro Smith Machine at 40%, 50%, 60%, 70%, and 80% of the participant's initial one-repetition maximum (1RM) for back squat and bench press.
At the end of the exercise training phase (Week 12), if a participant's 1RM has increased by less than 25%, power will be measured at the same relative loads.
If a participant's 1RM has increased by 25-49%, power will be measured at 50%, 60%, 70%, 80%, and 90% of the participant's initial 1RM (in this case, 90% of the participant's initial 1RM would not exceed 80% of the participant's post-training 1RM).
If a participant's 1RM has increased by 50% or greater, power will be measured at 60%, 70%, 80%, 90%, and 100% of the participant's initial 1RM (in this case, 100% of the participant's initial 1RM would not exceed 80% of the participant's post-training 1RM).
|
From enrolment (Week 1) to the end of the exercise training phase (Week 12)
|
|
Participant Satisfaction with the Exercise Program
Zeitfenster: At the end of the exercise training phase (Week 12)
|
Participant satisfaction with the exercise program will be measured using a modified Intrinsic Motivation Inventory (subscales of "Interest/Enjoyment", "Percieved Competence", "Effort/Importance", and "Value/Usefullness").
|
At the end of the exercise training phase (Week 12)
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Sponsor
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn (Tatsächlich)
12. August 2026
Primärer Abschluss (Geschätzt)
1. Juni 2027
Studienabschluss (Geschätzt)
1. Juni 2027
Studienanmeldedaten
Zuerst eingereicht
7. August 2026
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
7. August 2026
Zuerst gepostet (Tatsächlich)
12. August 2026
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
13. August 2026
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
11. August 2026
Zuletzt verifiziert
1. August 2026
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
- H26-01331
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
NEIN
Beschreibung des IPD-Plans
The dataset will contain potentially identifying information (age, height, and weight) of people in a relatively small geographic area, so individual participant data will not be shared with other researchers.
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Nein
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Nein
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .